Antitumor Activity of SPM VIII, a Derivative of the Nucleoside Antibiotic Spicamycin, Against Human Tumor Xenografts.
Journal of Antibiotics - United Kingdom
doi 10.7164/antibiotics.47.1305
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1994
Authors
Publisher
Japan Antibiotics Research Association